Nov 05, 2022
Extraction-Protocol-miRNA-SCALONMC
- Marcela Scalon1,
- Giane Regina Paludo1,
- Christine Souza Martins1,
- Ricardo Titze de Almeida1,
- Gabriel Ginani Ferreira1,
- Franciele Schlemmer1
- 1Universidade de Brasília
- Marcela Scalon
Protocol Citation: Marcela Scalon, Giane Regina Paludo, Christine Souza Martins, Ricardo Titze de Almeida, Gabriel Ginani Ferreira, Franciele Schlemmer 2022. Extraction-Protocol-miRNA-SCALONMC. protocols.io https://dx.doi.org/10.17504/protocols.io.ewov1oozolr2/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: November 03, 2022
Last Modified: November 05, 2022
Protocol Integer ID: 72245
Keywords: miRNA Purification, Plasma miRNA, Serum miRNA, Spike-in synthetic control, purified mirna material, purified mirna material with quality, total mirna, total rna, mirna, rna, guideline for the purification, qiagen cat, qpcr procedure, mirneasy mini kit, purification, serum sample, adaptation of qiagen supplementary protocol, peripheral blood collection, efficiency for qpcr procedure, qiagen supplementary protocol, qiagen, normalizing control of all purification, qpcr
Abstract
This protocol is intended as a guideline for the purification of total miRNAs, from serum and plasma, using the miRNeasy Mini Kit (QIAGEN cat. no. 217004). This is an adaptation of QIAGEN Supplementary Protocol for total RNA. The plasma samples were obtained from peripheral blood collection, stored in K3EDTA-containing tubes. The serum samples were obtained from peripheral blood collection, stored in non-additives tubes. Moreover, a synthetic spike-in control was included as a normalizing control of all purifications. The aim of this protocol is to provide purified miRNA material with quality and efficiency for qPCR procedures.
Materials
- miRNeasy Mini Kit (QIAGEN cat. no. 217004)
- QIAzol Lysis Reagent
Equipment and reagents to be supplied in addition to the kit:
- Chloroform (without added isoamyl alcohol)
- Ethanol (70% and 96–100%); do not use denatured alcohol, which contains other substances such as methanol and methylethylketone
- Sterile, RNase-free pipet tips
- 1.5 ml or 2 ml microcentrifuge tubes
- Microcentrifuge(s) (with rotor for 2 ml tubes) for centrifugation at 4°C and at room temperature (15–25°C)
- Disposable gloves
- miScript Serum/Plasma Spike-In Control (cel-miR-39p) for normalization and/or as an internal control
Safety warnings
When working with chemicals, always wear a suitable lab coat, disposable gloves, and protective
goggles. For more information, consult the appropriate material safety data sheets (MSDSs),
available from the product supplier.
Before start
- After collection and centrifugation, plasma or serum can be stored at 2–8°C for up to 6 hours or used directly in the procedure. For long-term storage, freezing at –20°C or –80°C in aliquots is recommended. Avoid prolonged incubation, which may compromise RNA integrity.
- Except for phase separation (step 7), all protocol and centrifugation steps should be performed at room temperature.
- The procedure is suitable for use with serum samples or with plasma samples containing either citrate or EDTA. Plasma samples containing heparin should not be used because this anticoagulant can interfere with downstream assays, such as RTPCR.
- Buffers RWT and RPE are supplied as concentrates. Before using for the first time, add the required volumes of ethanol (96–100%), as indicated on the bottle, to obtain a working solution.
- The Syn-cel-miR-39 miScript miRNA Mimic (cat. no. MSY0000010) can be added to samples to control for variations during the preparation of total RNA and subsequent steps, as it shows no sequence homology to any known human, mouse, or rat miRNA. miScript miRNA Mimics are provided lyophilized. Prepare the miScript miRNA Mimic stock and working solution as follows:
Stock - Add 300µl RNase-free water to lyophilized miScript Serum/Plasma Spike-In Control (10pmol). Final concentration will be 2 x 1010 copies/µl.
Dilution - Add 4µl stock (2 x 1010 copies/µl) to 16µl RNase-free water. Final concentration will be 4 x 109 copies/µl.
Working solution for RNA purification - Add 2µl of 4 x 109 copies/µl dilution to 48µl RNase-free water. Final concentration will be 1.6 x 108 copies/µl.
Prepare serum or plasma or thaw frozen samples:
- Aliquots has to have 100µl of plasma or serum.
Add 500µl of QIAzol Lysis Reagent. Mix by vortexing or pipetting up and down.
Note: After addition of QIAzol Lysis Reagent, lysates can be stored at -70ºC for severa months.
Place the tube containing the homogenate on the benchtop at room temperature (15-25ºC) for 5 minutes.
Note: This step promotes dissociation of nucleoprotein complexes.
Optional: Add 3.5µl of the working solution of Syn-cel-miR-39 miScript miRNA Mimic.
Add 1 volume chloroform to the tube containing the homogenate and close securely. Vortex the tube vigorously for 15 seconds.
Note: Thorough mixing is important for subsequent phase separation.
Place the tube containing the homogenate on the benchtop at room temperature for 2-3 minutes.
Centrifuge for 15 minutes at 12,000 x g at 4ºC. After centrifugation, heat the centrifuge up to room temperature (15-25ºC) if the same centrifuge will be used for the next centrifugation steps.
After centrifugation, the sample separates into 3 phases: an upper, colorless, aqueous phase containing RNA; a white interphase; and a lower, red, organic phase.
Transfer the upper aqueous phase to a new collection tube (supplied in the kit).
Avoid transfer of any interphase material. Add 1.5 volumes of 100% ethanol and mix thoroughly by pipetting up and down several times. Do not centrifuge. Continue without delay with step 9.
Write down the volume of the aqueous phase, multiply it by 1.5 to find the volume of ethanol to be added.
A precipitate may form after addition of ethanol, but this will not affect the procedure.
Pipet up to 700 μl of the sample, including any precipitate that may have formed, into an RNeasy Mini spin column in a 2 ml collection tube (both supplied in kit). Close the lid gently and centrifuge at ≥8000 x g (≥10,000 rpm) for 15 s at room temperature (15–25°C). Discard the flow-through.*
Reuse the collection tube in step 10.
* Flow-through contains QIAzol Lysis Reagent and is therefore not compatible with
bleach.
Repeat step 9 using the remainder of the sample. Discard the flow-through.*
Reuse the collection tube in step 11.
* Flow-through contains QIAzol Lysis Reagent and is therefore not compatible with
bleach.
Add 700 μl Buffer RWT to the RNeasy Mini spin column. Close the lid gently and centrifuge for 15 s at ≥8000 x g (≥10,000 rpm) to wash the column. Discard the flowthrough.*
Reuse the collection tube in step 12.
* Flow-through contains Buffer RWT and is therefore not compatible with
bleach.
Pipet 500 μl Buffer RPE onto the RNeasy Mini spin column. Close the lid gently and centrifuge for 15 s at ≥8000 x g (≥10,000 rpm) to wash the column. Discard the flow-through.
Reuse the collection tube in step 13.
Repeat step 12.
Note: Following centrifugation, remove the RNeasy Mini spin column from the collection tube carefully so the column does not contact the flow-through. Otherwise, carryover of ethanol will occur.
Place the RNeasy Mini spin column into a new 2 ml collection tube (not supplied in kit), and discard the old collection tube with the flow-through. Centrifuge in a microcentrifuge at full speed for 2 min.
The long centrifugation step dries the spin column membrane, ensuring that no ethanol is carried over during RNA elution.
Residual ethanol may interfere with downstream reactions.
Transfer the RNeasy Mini spin column to a new 1.5 ml collection tube (supplied in kit). Pipet 30–50 μl RNase-free water directly onto the RNeasy Mini spin column membrane. Close the lid gently and centrifuge for 1 min at ≥8000 x g (≥10,000 rpm) to elute the RNA.
Note: for a better miRNA recovery and higher miRNA concentration, use the eluted miRNA solution to make a second centrifuge step, in the same spin column, for 1 min at ≥8000 x g (≥10,000 rpm).